TickerFacts.

Company research / ACH

Accendra Health Inc (ACH)

Build a valuation ↗↓ Download CSV

SEC name ACCENDRA HEALTH INC/VA/ · CIK 0000075252 · NYSE · Wholesale-Medical, Dental & Hospital Equipment & Supplies

  • Sector Wholesale Trade
  • Incorporated VA
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Accendra Health Inc reported revenue of $2.76B. Revenue grew 3.1% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $2.65B.

Key ratios (year ended 2025-12-31)

46.7%
Gross margin (computed)
1.0%
Operating margin
-39.8%
Net margin
3.1%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-09

Headquarters locality: Mechanicsville · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$2.65B$2.76B$2.68B$2.55B$9.96B$9.79B$8.48B$9.21B$9.42B$9.32B$9.72B
Cost of Revenue$1.46B$1.47B$1.40B$1.34B$8.13B$8.27B$7.20B$8.08B$8.35B$8.15B$8.54B
Gross Profit (computed)$1.19B$1.29B$1.28B$1.22B$1.83B$1.51B$1.28B$1.13B$1.07B$1.17B$1.19B
R&D Expensen/an/a$13.00M$13.00M$12.00M$12.10Mn/an/an/an/an/a
Operating Income$29.35M$27.46M-$217.73M$133.23M$142.91M$368.47M$204.12M$73.15M-$352.35M$89.25M$199.60M
Depreciation & Amortizationn/a$214.52M$181.28M$210.37M$228.67M$90.62M$93.34M$116.68M$101.93M$59.44M$55.39M
EBITDAn/a$241.98M-$36.45M$343.60M$371.58M$459.09M$297.45M$189.83M-$250.42M$148.69M$254.99M
Net Income-$302.14M-$1.10B-$362.69M-$41.30M$22.39M$221.59M$29.87M-$62.37M-$437.01M$72.79M$108.79M
EPS (Diluted)n/a-$14.31-$4.73-$0.53$0.29$2.94$0.47-$1.03n/an/a$1.76
Total Assets$2.11B$2.45B$4.66B$5.09B$5.39B$3.54B$3.34B$3.64B$3.77B$3.38B$2.72B
Total Liabilities$2.66B$2.91B$4.07B$4.17B$4.44B$2.60B$2.62B$3.18B$3.26B$2.36B$1.76B
Long-Term Debtn/an/an/an/an/an/a$1.03B$1.56B$1.68B$917.36M$569.39M
Shareholders' Equity-$550.94M-$460.98M$586.36M$945.30M$945.60M$938.50M$712.05M$462.15M$518.42Mn/an/a
Cash & Equivalents$7.65M$281.99M$27.57M$243.04M$69.47M$55.71M$83.06M$67.03M$66.31M$104.52M$185.49M
Operating Cash Flow-$180.42M-$101.79M$161.50M$740.71M$325.01M$124.18M$339.22M$166.09M$115.59M$56.77M$187.69M
Capital Expendituresn/a$190.96M$170.29M$172.38M$158.09M$40.98M$50.42M$42.42M$44.87M$34.61M$20.30M
Free Cash Flown/a-$292.75M-$8.79M$568.34M$166.92M$83.19M$288.80M$123.67M$70.72M$22.16M$167.39M
Share Repurchasesn/a$10.18Mn/an/an/an/an/an/a$0$5.00M$71.03M
Dividends Paidn/an/an/a$0$0$731.0K$648.0K$5.23M$48.20M$63.15M$63.38M
Shares Outstanding76.91M76.39M77.20M76.55M76.28M75.43M73.47M62.84M61.48M61.48M61.03M
Dividends Per Sharen/an/an/an/an/a$0.01$0.01$0.01$0.86$1.03$1.02
Weighted Average Diluted Sharesn/a76.90M76.74M77.37M76.22M75.49M63.51M60.57Mn/a60.00M61.09M
EPS (Basic)n/a-$14.31-$4.73-$0.54$0.30$3.05$0.47-$1.03n/an/a$1.76

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView